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lowed by stenting in 22/26 (85%). Within median 5 days (range 0-14), 11/26 (42%) under-
went reoperative mitral (n=8) or aortic (n=3) valve surgery. The remaining 15 patients
underwent primary mitral (n=13), aortic (n=1) or double (n=1) valve surgery. Concomitant
CABG was performed to non-stented (non culprit) vessels in 9 primary mitral and 1 aortic
valve patients. Operative mortality was 3.8% (1/26). Survival at 1, 3 and 5 years was
78%, 56% and 44% respectively.
Conclusion: “Hybrid” initial PCI followed by staged valve surgery may represent an alter-
native to conventional valve/CABG in some high-risk patients, particularly those who
present in shock after myocardial infarction and some patients who require reoperative
valve surgery.
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851-4 Changing Outlook After Aortic Valve Surgery for 
Chronic Aortic Regurgitation With Severe Left 
Ventricular Dysfunction
Sunil K. Bhudia, Patrick M. McCarthy, Ganesh S. Kumpati, Katherine J. Hoercher, 
Jeevanantham Rajeswaran, Eugene H. Blackstone, The Cleveland Clinic Foundation, 
Cleveland, OH
Background: Historically, patients (pts) with chronic aortic regurgitation (AR) and severe
left ventricular (LV) dysfunction have been considered for transplant due to perceived
high operative mortality after aortic valve (AV) surgery and limited late survival. We
sought to determine change in hospital mortality over time, late survival compared with
pts without severe LV dysfunction, and risk factors for death after AV surgery.
Methods: From 1972 to 1999, 724 pts underwent AV surgery for chronic (>3 mo) AR; 88
(12%) had severe LV dysfunction (ejection fraction <30%). They were propensity
matched to pts with non-severe LV dysfunction to compare hospital mortality and time-
related survival. Propensity score adjusted multivariable analysis of all 724 pts was per-
formed to identify risk factors for death.
Results: Hospital mortality in pts with severe LV dysfunction has fallen to 0% (0/35) since
1985, comparable to that of propensity-matched pts with non-severe LV dysfunction
(Fig). Time-related survival in pts operated on from 1985 to 1999 was similar in both
groups (P=.96) and comparable to that of transplantation. Risk factors for death included
earlier date of surgery and severe LV dysfunction, but not interaction between them
(P=.5).
Conclusions: AV surgery in pts with severe LV dysfunction is no longer a futile, high-risk
procedure for which transplantation is the only option. Neutralization of severe LV dys-
function has been accomplished by across-the-board improvement in early results of AV
surgery. 
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851-5 Hemodynamic Response to Inhaled Nitric Oxide in 
Adult Cardiac Surgery
Frank D. Wagner, Tom Gromann, Deutsches Herzzentrum Berlin, Berlin, Germany
Background: Inhaled nitric oxide (iNO) has been established as a selective pulmonary
vasodilator in the treatment of pulmonary hypertension associated with acute right ven-
tricular (RV) failure. This study reviews our single-center experience with the use of iNO
in adult cardiac surgery.
Methods: We retrospectively evaluated 600 patients (mean age 55±16 years; 408 male,
192 female) treated postoperatively with iNO between 1997 and 2002. Patients pre-
sented with acute pulmonary hypertension after heart transplantation HTx (n=164),
CABG (n=115), left ventricular assist device (LVAD) implantation (n=82), lung transplan-
tation (n=54), mitral valve replacement (n=39), pulmonary thromboendarterectomy
(n=26) and other operations (n=62), and were treated with NO inhalation initiated on
weaning from cardiopulmonary bypass. Hemodynamic parameters were measured prior
to iNO, at 1, 2, 6, 12, 24 and 48 hours during iNO therapy and after weaning from iNO.
Rebound pulmonary hypertension was prevented by slow weaning.
Results: Prior to iNO PVR, mean PAP and CO for the whole group were 242±140
dynesxsxcm-5, 28±10 mmHg and 5.1±1.7 L/min resp., with high inotropic support (epi-
nephrine 0.24±0.16 µg/kg/min). At 6 hours after institution of iNO (mean dose 18±13
ppm) PVR and mean PAP decreased (135±113 dynesxsxcm-5 and 26±9 mmHg
(p<0.0001) and CO increased (5.7±1.7 L/min (p<0.0001). Hemodynamics improved fur-
ther within 48 hours and the epinephrine dose was progressively reduced (p<0.0001).
Patients were weaned from iNO within 32±35 hours. Irrespective of the etiology of pulmo-
nary hypertension the pulmonary vasodilating effect of iNO was proportional to the mean
PAP prior to therapy, whereas the resultant increase in CO was dependent on the extent
of RV dysfunction. Hemodynamic improvement was more pronounced after LVAD
implantation and HTx than after other operations.
Conclusion: In patients presenting with acute pulmonary hypertension after cardiac sur-
gery iNO selectively reduced right ventricular afterload, thereby effectively improving car-
diac output. Beneficial hemodynamic effects of iNO were dependent on the degree of RV
dysfunction and more pronounced after LVAD implantation and HTx.
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851-6 Diffusion Weighted Magnetic Resonance Imaging and 
Neurocognitive Outcomes in Atherosclerotic Patients 
Undergoing Off-Pump Coronary Artery Bypass Surgery
Ehtasham A. Qureshi, Adnan Siddiqui, Khalid M. Zirvi, Karthik Linganathan, Francis 
Sutter, Bruce Caplan, Andrew J. Curtin, Amid Khan, Naushad Shaikh, Gary Friday, 
James F. Burke, The Lankenau Hospital and Research Institute, Wynnewood, PA
Background: Reports of neuro-cognitive deficits following off-pump coronary artery
bypass surgery (OPCABG) are conflicting.These deficits, thought to be secondary to
brain ischemia, have not been evaluated using diffusion-weighted magnetic resonance
imaging (DW-MRI), a sensitive method to detect new ischemic lesions.
Methods: Neurocognitive outcomes were assessed in 17 random patients, mean age 70
± 16 (88% males) undergoing OPCABG. Brain DW-MRI was performed before and after
OPCABG in all patients and evaluated for new ischemic lesions by a neuroradiologist
blinded to the clinical data. All patients were assessed and scored for neuropsychological
impairment by the consensus of two independent neurologists using the standard
National Institute of Health Stroke Scale (NIHSS) and a battery of neurocognitive tests
both before and after the surgery.
Results: New focal lesions were seen in 6 (33%) patients, 4 of these were also found to
have neurocognitive decline as assessed by neuropsychological testing. The clinical and
procedural characteristics were similar in patients with and without new DW-MRI
changes. There was no evidence of definitive clinical stroke, as defined by the NIHSS, in
any patient. No patient had pre-operative atrial fibrillation and 4 (23%) developed atrial
fibrillation after OPCABG; none of these patients had any new ischemic lesions on DW-
MRI.
Conclusions: This study suggests that in patients undergoing OPCABG, ischemic brain
lesions occur frequently and factors other than cardiopulmonary bypass maybe impli-
cated for these findings. Further studies with larger number of patients are needed to
determine the clinical significance, predictors and long-term outcome of brain ischemia
following OPCABG.
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1162-135 Intravenous Wafarin Sodium for Anticoagulation After 
Valve Replacement Surgery
Jerome B. Riebman, Thomas Wentzein, Catherine Weirshauser, Michael Nathanson, 
Santa Clara Valley Medical Center, San Jose, CA
BACKGROUND – After valve surgery, oral wafarin sodium (WS) anticoagulation therapy
is delayed due to postoperative coagulopathy and impaired oral medication absorption.
We evaluated the impact of combining initial intravenous wafarin (IVW) therapy during the
first 24 hours postoperatively with traditional postoperative oral WS therapy.
METHODS - Adults (n=22, age 53.8±2.9 mean±SEM, 12 males) undergoing mechanical
valve implantation received 1-2 doses of IVW postoperatively and after 24-48 hours were
continued on oral WS. IVW (2.5-5 mg) was given the night of surgery or the following
morning (POD#0). A second dose of IVW (2.5-7.5 mg) was given during the second 24
hrs (POD#1) if the patient still was not tolerating oral intake. Subsequent daily oral WS
was given in the evenings, and titrated to an INR between 2.0-3.0. Patients were followed
until POD#14 or hospital discharge. A sex and age matched cohort of valve patients
(n=22, age 52.7±2.5, 12 males) receiving standard oral WS served as a comparison pop-
ulation.
RESULTS – Both groups were similar in medical history, operative variables, transfusion
requirements, thoracic drainage, and outcomes. The study patients received a total mean
dose of 8mg IVW followed by daily oral WS dosing. Cohort patients started oral WS
POD#1 or after. Patients receiving IVW followed by oral WS reached therapeutic INR in
3.4±0.42 days compared to 4.9±0.28 days for oral WS only patients (P<0.05).
CONCLUSION – Early postoperative IVW was not associated with negative clinical
events. Patients receiving initial IVW then oral WS reached therapeutic INR more quickly
than patients receiving oral WS only. Safe, earlier anticoagulation can be accomplished
with combination therapy, and may translate in to reductions of hospital stay and costs.
1162-136 Durability and Outcomes of Mitral Valve Repair for 
Infective Endocarditis
Yukikatzu Okada, Ko Bando, Hitoshi Kasegawa, Kobe City General Hospital, Kobe, 
Japan, National Cardiovascular Center, Osaka, Japan
Background: Mitral valve (MV) repair over replacement has significant advantages for
patients with infective endocarditis (IE). However, the durability and late outcome of MV
repair for IE remains to be determined. We sought to determine the risks for mortality,
